Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
NegativeWorld Affairs
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Kimberly-Clark's decision to acquire Kenvue, the maker of Tylenol, for $40 billion has raised eyebrows among analysts. This move comes at a time when Tylenol's sales have been declining, particularly after the White House made controversial links between the product and autism. The implications of this acquisition are significant, as it reflects the challenges faced by major pharmaceutical companies in maintaining consumer trust and navigating public perception.
— via World Pulse Now AI Editorial System





